A preclinical study conducted by a team of scientists at the Institute for Bioengineering of Catalonia highlights the therapeutic potential of nanorobots in bladder cancer treatment.

Sangamo Therapeutics developed a novel capsid that achieved outstanding results in a preclinical study, this could have significant implications for treating neurological disorders.

A preclinical study conducted by a group of researchers at the University of Pennsylvania shows promise in treating cystic fibrosis using RNA therapeutics.

Advancements in RNA therapeutic delivery are extending beyond liver-specific treatments, addressing complex challenges and enabling broader applications in medicine. Innovations in lipid nanoparticles, RNA interference, and artificial intelligence are key to this progress, offering potential treatments for a range of diseases and moving closer to personalized medicine. Despite remaining challenges, these developments mark significant strides towards transformative patient care.

Research efforts aim to investigate whether an inhaled version of the tuberculosis (TB) vaccine, Bacille Calmette-Guérin (BCG) is more effective than the traditional intradermal method of delivery.

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

Delve into the specifics of inhaled gene therapy, its mechanisms, applications, and future prospects, it's essential to appreciate the foundational principles of gene therapy that paved the way for these advancements.

With ongoing dose escalation and expansion, CRB-701 holds promise as a next-generation treatment for patients battling advanced cancers.

Dive into the progress and challenges in Antibody-Drug Conjugates formulation and delivery for cancer treatment. We emphasize the advancements in targeting precision and efficacy, while discussing key development challenges like target selection, drug potency, and manufacturing complexities in this evolving oncology field.

Millions use inhalers to treat pulmonary conditions in the UK. What is their environmental impact, and how can they be improved for a sustainable future?

Explore the groundbreaking advancements in inhaled drug delivery, a transformative approach that promises enhanced efficacy and patient convenience

The microneedle drug delivery skin patch is made of hydrogel, making it cheap and sustainable to produce.